Halima Moncrieffe, PhD

Academic Affiliations

Assistant Professor, UC Department of Pediatrics

Phone 513-636-4676

Email halima.moncrieffe@cchmc.org

Juvenile idiopathic arthritis; inflammation; biomarkers; autoimmune disease; pharmacogenomics
Halima Moncrieffe, PhD, is an immunologist who has basic and translational research interests in mechanisms of childhood arthritis susceptibility and immunopathology. She studies how genetic and immunological variants contribute to inflammation and response to medication.
PhD: Imperial College London, London, United Kingdom.

View PubMed Publications

Clement CC, Moncrieffe H. Lele, A, Janow HG, Becerra A, Bauli F, Saad FA, Perino G, Montagna C, Cobelli N, Hardin J, Stern LJ, Ilowite N, Porcelli SA, Santambrogio L. Autoimmune response to transthyretin in juvenile idiopathic arthritis. JCI Insight. 2016;1(2):e85633.

Botta Gordon-Smith S, Ursu S, Eaton S, Moncrieffe H, Wedderburn LR. Correlation of low CD73 expression on synovial lymphocytes with reduced adenosine generation and higher disease severity in juvenile idiopathic arthritis. Arthritis Rheumatol. 2015 Feb;67(2):545-54.

Moncrieffe H, Prahalad S, Thompson SD. Genetics of juvenile idiopathic arthritis: new tools bring new approaches. Curr Opin Rheumatol. 2014 Sep;26(5):579-84.

Cobb J*, Cule E*, Moncrieffe H*, Hinks A, (*joint first authors). Genome-wide data reveal novel genes for methotrexate response in a large cohort of juvenile idiopathic arthritis cases. Pharmacogenomics J. 2014 Aug;14(4):356-64.

Moncrieffe H, Ursu S, Holzinger D, Patrick F, Kassoumeri L, et al. A subgroup of juvenile idiopathic arthritis patients who respond well to methotrexate are identified by the serum biomarker MRP8/14 protein. Rheumatology (Oxford). 2013 Apr 25.

Mulligan K, Kassoumeri L, Etheridge A, Moncrieffe H, et al. Mothers’ reports of the difficulties that their children experience in taking methotrexate for Juvenile Idiopathic Arthritis and how these impact on quality of life. Pediatr Rheumatol Online J. 2013 May 28;11(1):23.

Holzinger D, Frosch, M, Kastrup, A, Otten, MH, Prince, FHM Suijlekom-Smit, LWA, ten Cate R, Hoppenreijs EPAH, Hansmann S, Moncrieffe H, Ursu S, Wedderburn L, Roth J, Foell D and Wittkowski H. The Toll-like receptor 4 agonist MRP8 and MRP14 protein complex is a sensitive indicator for disease activity and predicts relapses in Systemic-Onset Juvenile Idiopathic Arthritis. Ann Rheum Dis. 2012 Jun;71(6):974-80.

Hinks A, Moncrieffe H, Martin P, Ursu S, Lal S, Kassoumeri L, Weiler T, Glass DN, Thompson SD, Wedderburn LR, Thomson W. Association of the 5-aminoimidazole-4-carboxamide ribonucleotide transformylase (ATIC) gene with response to methotrexate in juvenile idiopathic arthritis (JIA). Ann Rheum Dis. 2011 Aug;70(8):1395-400.

Moncrieffe H, Nistala K, Kamhieh Y, Evans J, Eddaoudi A, Eaton S, Wedderburn LR. High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T cell population. J Immunol. 2010 Jul 1;185(1):134-43.

Moncrieffe H, Hinks A, Ursu S, Kassoumeri L, Etheridge A, Hubank M, Martin P, Weiler T, Glass DN, Thompson SD, Thomson W, Wedderburn LR. Generation of novel pharmacogenomic candidates in response to methotrexate in juvenile idiopathic arthritis: correlation between gene expression and genotype. Pharmacogenet Genomics. 2010 Nov;20(11):665-76.

Nistala K, Moncrieffe H, Newton KR, Hunter P, Wedderburn LR. Human IL-17 producing T cells show a reciprocal relationship to Foxp3+ regulatory T cells in childhood arthritis. Arthritis Rheum. 2008 Mar;58(3):875-87.